Breast cancer is one of the most common cancers in women worldwide, as one in every eight females will be diagnosed with this disease in their lifetime 1 . Current treatments for this type of cancer are mastectomy, chemotherapy, radiation and hormone therapy, among others; but the downside of these treatments is that the rate of success is very low in advanced stages of the disease 2-4 , mainly because secondary niches in breast cancer are multi-tissue and, in consequence, the location of the residuary is unpredictable 5-7 . This second niche can localize to lymph
Inserts were fixed, stained with DAPI and nuclei were counted. (F) Anchorage-independent growth was evaluated in 12-well plates, in which 2 × 10 3 Tb-negative MDA-MB-231 cells, transfected as in (A), were seeded onto soft agar. Colony formation capacity was evaluated after 21 days in culture. (G) Whole-well microphotographs of colonies and zoom-in under phase contrast microscopy at 4X and 10X magnification. All quantitative data shows average measurement from three independent experiments in triplicate. Statistically significant differences with respect to non-treated cells are indicated (**p < 0.01, ***p < 0.001). L, cells treated with Lipofectamine 2000; C, cells transfected with ASO-C and 1537 S, cells transfected with ASO-1537S. 24 h after transfection, when the percentage of apoptotic cells was approximately 50%. A higher proportion of exosomes per cell was obtained from ASO-1537S-treated cells ( Fig. 2A ). Purified vesicle integrity was confirmed by Transmission Electron Microscopy (TEM) ( Fig. 2B ) and expected particle size distribution was confirmed using Nanoparticle Tracking Analysis (NTA), showing exosome diameters ranging from 103 to 124 nm (Fig. 2C) . Additionally, Western blot analysis confirmed the presence of the classical exosome markers CD9, TSG101, Alix and Rab27a in all exosome preparations. Calnexin and HSP60 were used to discard cell lysate contamination with proteins from the endoplasmic reticulum and mitochondria, respectively (Fig. 2D) . These results show that the purified vesicles did not harbor cell lysate contaminants and were highly enriched in exosomes. To discard the presence of ASO-C or ASO-1537S in the exosomes, we transfected cells in the same manner described above, using Alexa fluor 488-labeled ASO-1537S or Cy3-labeled ASO-C, where we observed around 98% transfection efficiency ( Supplementary Fig. S1B ). Purified exosomes obtained after 24 h of transfection displayed no detectable fluorescence ( Supplementary Fig. S1C ). In addition, RT-PCR confirmed that exosome preparations were also devoid of ASncmtRNAs ( Supplementary Fig. S2 ). These results were not unexpected since treatment with ASO-1537S induces knockdown of ASncmtRNAs 34,37,39 . Exo-WT, Exo-C and Exo-1537S exosomes released from transfected MDA-MB-231 cells are incorporated into wild type MDA-MB-231 cells. Exo-WT, Exo-C and Exo-1537S exosomes were loaded with the fluorescent dye PKH67 (green), washed to eliminate free dye, and quantified by NTA. MDA-MB-231 cells were incubated with the different exosomal preparations at a density of 1000 exosomes per cell. Internalization of labeled exosomes into MDA-MB-231 cells was measured by flow cytometry and confocal microscopy. The maximum percentage of intensity for the green signal in cells measured by flow cytometry was 26.4 ± 0.2%, 14.5 ± 0.8% and 25.9 ± 0.7% for MDA-MB-231 cells exposed to Exo-WT, Exo-C and Exo-1537S, respectively ( Fig. 2E) . Additionally, the presence of exosomes (green signal) was readily observed in the cytoplasm (red signal) of recipient cells by confocal microscopy (Fig. 2F ). Since there was no difference in the intensity of fluorescent signals, the incorporation of exosomes into cells was successfully achieved using all three exosome preparations.
Exo-1537S decrease proliferation of MDA-MB-231 cells.
MDA-MB-231 cells were incubated during different time points (6, 24 and 48 h) with exosomes (equivalent to 1 µg/mL total protein). After incubation, exosome-containing media was replaced by fresh culture media and proliferation was determined by MTT assay at 24, 48 and 72 h after media change (Fig. 3A ). After 6 h of exosome incubation, there was no difference in cell proliferation ( Fig. 3B ). However, cells incubated for 24 h and 48 h with Exo-1537S decreased at least 3 times their proliferation rate compared to untreated cells or cells exposed to Exo-WT or Exo-C ( Fig. 3B ). Cell proliferation decreased to a minimum at 48 h, after which proliferation showed only a modest recovery.
In order to assess whether this effect in proliferation is related to the inner content of the exosomes, we pre-treated Exo-1537S with proteinase K, RNase A or sonication before adding them to MDA-MB-231 cells. As shown in Fig. 3C , RNase A pre-treatment did not reverse the antiproliferative effect of Exo-1537S, suggesting that putative RNAs that could be adhered to the outer surface of the exosomes do not play a role in this process. In contrast, and as expected, sonication of Exo-1537S caused a loss in the anti-proliferative effect of these exosomes. Moreover, proteinase K treatment also reversed the anti-proliferative activity of these exosomes, suggesting that external or transmembrane proteins present in the membranes of exosomes are responsible for the lower proliferation rates observed. To determine the effect of exosomes on viability, MDA-MB-231 cells were incubated with the exosomal preparations for 6, 24 or 48 h, after which exosome-containing media was removed and cells were further cultured in freh media for 48 h. Cell death was assessed by Tb exclusion assay. A strong decrease in the percentage of viable cells was observed when incubated with Exo-1537S for 24 or 48 h, compared to controls ( Fig. 3D ). Similar results were obtained by PI staining followed by flow cytometry of cells treated for 24 h with exosomal preparations or left untreated and then cultured for 48 h in fresh media. The results showed that Exo-1537S treated cells displayed an average proportion of 52% PI-positive cells, compared to 18, 22 and 24% in controls ( Fig. 3E ).
Exo-1537S decreases invasive capacity, spreading and colony formation of breast cancer cells.
Considering that incubation of MDA-MB-231 cells with Exo-1537S for 6 h did not affect their proliferation rate, (Fig. 3B ), we evaluated whether other tumorigenic capacities were altered. MDA-MB-231 cells were pre-incubated with exosomes for 6 h, and cells were further cultured for 48 h. Cells were then collected and used to determine invasion for 48 h. We observed a two-fold decrease in invasion capacity in cells exposed to Exo-1537S vesicles compared to cells exposed to control vesicles ( Fig. 4A,B ). Of note, untreated cells and cells exposed to Exo-WT or Exo-C did not display any differences between each other in terms of invasion capacity (Fig. 4A,B ). To evaluate the movement of cells in a matrix, we measured cell spreading on fibronectin-coated coverslips after being exposed to exosomes for 6 h. Spreading decreased at least 2-fold in cells exposed to Exo-1537S vesicles compared to cells exposed to Exo-WT vesicles (Fig. 4C,D) . We also evaluated the anchorage-independent growth ability of MDA-MB-231 cells exposed to Exo-1537S, by colony formation in soft agar. Cells were pre-incubated with 10 µg (protein content) of exosomes for 24 h, after which cells were seeded in soft agar and colonies > 100 µm in diameter were scored at 21 days. Exo-1537S vesicles almost completely suppressed clone formation compared to cells incubated with control vesicles (Fig. 4E,F) . For comparison, we evaluated the effects of Exo-1537S on invasiveness of two less aggressive human breast cancer cell lines, T47D and MCF7, exposed to exosomes. Invasion capacity of T47D cells exposed to Exo-1537S showed a significant decrease compared to controls, albeit modest when compared to MDA-MB-231 cells (Fig. G, H) . In MCF7 cells, an increase in invasion potential of about 5 times was observed when incubated with Exo-WT and Exo-C exosomes, compared to untreated cells ( Fig. 4I ), suggesting that the content from those exosomes potentiated the tumorigenic property of this cell line. However, . Bars indicate the diameter of some exosomes. (C) Exo-WT, Exo-C and Exo-1537 S samples were diluted so as to count 10 to 100 particles per record. The latter were then analyzed to determine the size with an approximation of the quantity of particles (concentration). The graph shows size distribution and number of particles in relation to diameter, with a mean diameter between 103 at 124 nm. (D) 30 µg of total exosome protein content of each sample was used to evaluate the classical exosome markers by Western blot: CD9, TSG101, ALIX and Rab27a. Calnexin and HSP60 were used as negative controls. A representative result for each blot is shown (n = 3). (E) Exosomes (Exo-WT, Exo-C and Exo-1537S) were labeled with the fluorescent dye PKH67 (green signal) and the number of exosomes was quantified by NTA. To perform the internalization protocol, labeled exosomes were added to MDA-MB-231 cells (1000 exosomes per cell), and then incubated for 3 h at either 37 °C or 4 °C. The internalization of Exo-WT, Exo-C and Exo-1537S exosomes into MDA-MB-231 cells was evaluated by fluorescence-activated cell sorting (FACS). Data was presented as percentage of signal intensity (n = 3) and was also visualized by confocal microscopy (F), where the cytoplasm was stained with 2 µM CellTracker ™ Red CMTPX (red signal), exosomes were labeled with PKH67 (green) and the nucleus was counterstained with DAPI (blue). A representative image of Exo-1537 S internalization into MDA-MB-231 cells is shown (magnification 100 × ).
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(2020) 10:343 | https://doi.org/10.1038/s41598-019-57018-1 www.nature.com/scientificreports www.nature.com/scientificreports/ www.nature.com/scientificreports www.nature.com/scientificreports/ Exo-1537S incubation was able to reverse this effect ( Fig. 4I ). Similar results were obtained for colony formation in MCF7 cells, in which incubation with Exo-WT or Exo-C enhanced anchorage-independent growth, but Exo-1537S reversed this effect ( Fig. 4J ).
Tumorigenesis of MDA-MB-231 cells in an in vivo
breast cancer carcinomatosis model is enhanced by Exo-WT and Exo-C and decreased by Exo-1537. Three groups of 7 BalbC NOD/ SCID mice, 5-7 weeks of age, were injected intraperitoneally (ip) with 2.5 × 10 6 MDA-MB-231 cells, together with Exo-WT, Exo-C or Exo-1537S (10 μg per mouse). A separate control group of 7 mice was inoculated with cells + saline only and another group of 6 mice was left uninoculated (NT). Injections were performed in a blinded fashion. At 21 days, all animals were sacrificed under anesthesia and tumor/mesentery mass, retroperitoneal tumor and malignant ascites were collected ( Fig. 5A ). Solid tissues were fixed and weighed. The average total tumor/mesenteric mass (g) in mice inoculated with Exo-WT (0.44 ± 0.004 g) and Exo-C (0.47 ± 0.006 g) was significantly higher than in mice injected with cells only (saline; 0.26 ± 0.0062 g). In striking contrast, Exo-1537S co-injection inhibited tumor growth compared to the saline group, reaching an average of 0.16 ± 0.003 g and showed a mesenterial mass slightly higher than uninoculated mice (NT; 0.07 ± 0.003 g) ( Fig. 5B ). Conclusively, Exo-WT and Exo-C-treated mice exhibited average tumor sizes of 0.37 and 0.4 g, respectively, corresponding to approximately twice the size of mice inoculated with cells alone (0.19 g). In contrast, Exo-1537S-treated mice displayed tumors that were, on the average, half the mass of the saline group (0.09 g), showing that, in vivo, these exosomes also inhibit MDA-MB-231 cell proliferation.
Similar findings were observed for retroperitoneal tumor/spleen mass. The mice that received Exo-WT and Exo-C showed a total average mass of 0.40 ± 0.05 and 0.29 ± 0.06 g, respectively, compared to mice injected with cells only (saline; 0.22 ± 0.06 g). Exo-1537 S-treated mice, on the other hand, showed an average total mass of 0.087 ± 0.01, again only slightly higher than uninoculated mice (0.051 ± 0.005 g) ( Fig. 5C ). This means that control exosomes, Exo-WT and Exo-C, augmented the retroperitoneal tumor mass 2-and 1.4-fold, respectively, while Exo-1537S decreased tumor mass approximately 4.7-fold, compared to the saline group.
Development of malignant ascites was only observed in mice treated with Exo-WT and Exo-C (9,6 × 10 10 and 3,4 × 10 11 cells/ml, respectively) ( Fig. 5D ), while in the saline group, the number of cells found in the abdominal cavity was lower than 180.000 cells/mL ( Fig. 5E ).
MDA-MB-231 cells release exosomes with differential molecular content after ASncmtRNA knockdown. A strong decrease of tumorigenic properties in MDA-MB-231 cells is observed after incubation
with Exo-1537 S vesicles and, conversely, an increase in these properties is attained with Exo-WT and Exo-C vesicles. Therefore, we sought to determine which components of the molecular cargo of the extracellular vesicles are responsible for these effects. For this purpose, we performed a proteomic analysis of each exosome preparation. A Venn diagram of the results shows that 137 proteins are unique to Exo-WT vesicles, 17 proteins are exclusive for Exo-C and 27 proteins are unique for Exo-1537S vesicles (Fig. 6A ). The latter contained at least 6 subunits of the proteasome complex and mostly proteins associated to the actin cytoskeleton (Supplementary Material Mass Spectrometry Analysis). Comparison among all three exosome pools yielded 96 proteins in common, in which the majority corresponded to histones, complement system proteins, Fibrinongen, Lactoferrin and Apolipoproteins (Supplementary Material Mass Spectrometry Analysis). Five proteins were shared only by Exo-WT and Exo-C ( Fig. 6A ). To gain insight into signaling pathways that might be controlled by the proteins enriched in Exo-WT, Exo-C and Exo-1537S vesicles, we performed a GO analysis (PANTHER) and detailed pathway analysis proteins obtained by using a Reactome platform. The Gene Ontology (GO) enrichment analysis of Exo-1537S proteins only found in this sample (27 proteins) is depicted in Fig. 6B , showing the 8 most significantly enriched gene categories. We then performed GO enrichment analysis of the subgroup of genes categorized under "Cellular process", showing the 8 most-enriched gene categories among this group (Fig. 6C, left panel) . The results showed several protein candidates representing each enriched category: RabGDP, HSP70, Tubulin Beta 1 Chain, Histone H2A type 1-H, Histone H1.2, Coactosin-like protein, 3-oxo-5-beta-steroid 4-dehydrogenase and UTP-glucose-1-phosphate uridyliltransferase (Fig. 6C, right panel) . Likewise, we carried out a GO enrichment analysis of the 159 proteins found only in Exo-WT and/or Exo-C preparations (Fig. 6A) , where we observed 10 significantly enriched gene categories (Fig. 6D ). Further GO analysis of the genes categorized under "Cellular process" rendered 14 enriched categories (Fig. 6E, left panel) . Among these proteins we found Lactadherin, VE-cadherin (Cadherin-5), MMP9, S100A7, S100A9, Ras-related protein Rap-2b, Integrin β-1, Moesin and Rho-related GTP-binding protein RhoC (Fig. 6E, right panel) .
In summary, the proteomic analysis allowed us to determine the presence of proteins contained differentially in Exo-1537, compared to the controls, Exo-C and Exo-WT. In the latter two preparations, we detected the presence of VE-Cadherin (CDH5) and Lactadherin (MFG-E8) and several members of the S100 family of proteins reported to participate in organotropic breast cancer metastasis 40 . In order to corroborate these findings, we performed Western blot analysis, in which we detected the presence of the invasion-promoting protein candidates VE-Cadherin and Lactadherin (Fig. 6F ), but the other candidates assayed did not display differential expression between controls (Exo-WT and Exo-C) and Exo-1537S particles (Fig. 6F) . The levels of all the proteins analyzed showed no difference in total cell lysates ( Fig. 6F) , confirming that the exosome treatments did not alter the expression of these protein genes. cells were evaluated in invasion assays like MDA-MB-231 and T47D. J) MCF7 cells were grown alone or in the presence of 10 µg Exo-WT, Exo-C or Exo-1537S for 24 h, after which they were seeded onto soft agar. Colonies were scored at 21 days (***p < 0.001, n = 3). 
Discussion
ASncmtRNA knockdown causes significant cell death in a wide array of cancer cell lines [35] [36] [37] 41 . The percentage of cell death varies among cell lines 35 and, as our results show, this percentage is around 16-40% in several breast cancer cells at 24 h (Fig. 1A) . The question that arises is whether the remaining live cells at 24 h post-transfection preserve their tumorigenic potential or lose these traits upon treatment. As shown in Fig. 1E -G, after ASncmtRNA knockdown remnant cells drastically reduce their invasive and anchorage-independent growth capacities. The mechanisms underlying the effects of ASncmtRNA knockdown on tumor cells is not completely understood. A proposed mechanism involves the emergence of miRNAs that target survival factors such as survivin, thus triggering apoptosis 35 . In the present study we aimed at a different approach, which was to isolate extracellular vesicles that are released after ASncmtRNA knockdown at 24 h post-transfection of MDA-MB-231 breast cancer cells (where we found approximately 60% live cells), since these vesicles might contain molecules (proteins or RNAs) which could affect target cells. Exosomes purified post-knockdown of ASncmtRNA displayed similar size and distribution as those isolated from ASO-C-treated and untreated cells (Fig. 2B,C) . Detection of the exosome markers ALIX, TSG101, CD9 and Rab27a 42 confirmed the exosomal nature of the vesicles (Fig. 2D) . Thus, in the three experimental conditions, exosomes are similar in appearance but may differ in their content and in their behavior.
Proliferative rate of tumor cells is highly related to metastasis 42, 43 . Accordingly, an incubation time of 24 h or more with exosomes modulates MDA-MB-231 tumor cell proliferation (Fig. 3B ). External treatment of Exo-1537S with RNase A prior to incubation with cells exerts no effect on the antiproliferative activity of these vesicles (Fig. 3C) , excluding the possibility that the observed effects are due to RNAs adhered to the outer side of their membranes. Sonication, on the other hand, precluded said effect of these exosomes (Fig. 3C ), suggesting that integrity of the vesicles is essential for their activity. External treatment with proteinase K also affected their ability to block proliferation ( Fig. 3C ), suggesting the presence of surface or transmembrane proteins which could be directly involved in the effects on proliferation or in docking and internalization of exosomes. Altogether, these results suggest that the effects of Exo-1537S vesicles on proliferation of target cells are due to their cargo, which could be proteins and/or RNAs. www.nature.com/scientificreports www.nature.com/scientificreports/ Tumorigenic properties of MDA-MB-231 cells such as migration, invasion, spreading and anchorage-independent growth are also diminished in the presence of Exo-1537S (Fig. 4) . Each of these characteristics are part of different stages of metastasis 44 . Our results suggest that the first metastatic behavior affected is migration and consequently spreading, since a 6 h incubation of cells with Exo-1537S was sufficient to visualize a decrease in these properties (Fig. 4A-D) . Proliferation and anchorage-independent growth are affected after 24 h of incubation with Exo-1537S and invasion is decreased only after 48 h of exosome incubation. On the other hand, our results in a murine xenograft peritoneal carcinomatosis model showed that Exo-1537S injection, in conjunction with MDA-MB-231 cells, displayed a strong reduction in tumor growth compared to Exo-WT and Exo-C and, furthermore, reduced the size of mesenteric and retroperitoneal tumor mass, even compared to cells injected alone (Fig. 5B,C) , suggesting that the molecular cargo of Exo-1537S contains factors that inhibit tumorigenesis. Furthermore, Exo-WT and Exo-C vesicles promoted tumor growth beyond that of cells-only-injected mice (Fig. 5B,C) . These in vivo results strongly suggest that exosomes released from control cells contain factors that enhance tumorigenic properties, while exosomes secreted upon ASncmtRNA knockdown harbor factors that promote the opposite outcome, similar to the effects brought upon directly by transfection of a myriad of tumor cell types with ASO-1537S 34, 37, 39 .
Exo-WT and Exo-C vesicles enhanced invasiveness and anchorage-independent growth potential of MCF7 cells, a cell line of lower aggressiveness than MDA-MB-231, whilst Exo-1537S vesicles revert this effect (Fig. 4I,J) . Furthermore, T47D cells, another human breat cancer cell line, undergo a significant decrease in their invasion capacity in the presence of Exo-1537 S vesicles (Fig. 4G,H) . It has been reported that breast cancer cells could increase their metastatic potential by receiving exosomes secreted by metastatic cell lines 45 , although this report does not describe which proteins might be participating in this behavior. Exosomes trigger these effects by delivering their vesicle content to recipient cells in a paracrine or autocrine manner 46 . Nevertheless, there are very few studies regarding the effects of exosome content in breast cancer cells 47 , even though it has been suggested that they could be potential tumour and metastasis markers in this cancer type 47, 48 .
A recent report showed that breast cancer exosomes enriched in α6β4 and α6β1 integrins were able to promote lung-specific metastasis 47 . On the other hand, αvβ5 integrin in exosomes was responsible for promotion of liver metastasis. This research does not discard micrometastasis to other tissues or the fact that this type of homing may be exclusive of integrins or members of the S100 family of proteins collaborating in targeting certain organs for metastasis [49] [50] [51] . It should be noted that the authors also showed that metastasis is not a random process 47, 48 .
Our proteomic analysis shows that Exo-WT and Exo-C contain a set of proteins that are absent from Exo-1537S (Fig. 6 ). Among these proteins, we focused on VE-Cadherin and Lactadherin, which have been suggested to play a role in the increase of tumorigenic properties [52] [53] [54] [55] [56] . We corroborated this data with Western blot analysis, which showed the differences in the expression of these two proteins comparing the control vesicles (Exo-WT and Exo-C) with Exo-1537 S (Fig. 6) .
VE-Cadherin is a well-known factor for increased vascular permeability in estrogen-positive breast cancer 57 and its expression correlates with poor survival prognosis in human gastric cancer and can therefore be used as a biomarker 58, 59 . VE-Cadherin expression has been related to melanoma 60 and breast cancer progression 61 . Nevertheless, the presence of VE-Cadherin in exosomes or the possible effects that these vesicles may have in the tumorigenic potential of breast cancer cells has not been previously determined. Lactadherin, on the other hand, regulates Cyclin D1 and D3 expression, leading to an increase in tumorigenic potential of epithelial breast cancer cells 54 . These evidences support our results on promotion of aggressiveness of a non-metastatic cell line such as MCF7, in terms of enhancement of migration, invasion and anchorage-independent growth of recipient cells 45 . This type of event could probably favor the communication among tumor cells of different aggressiveness within the tumor itself and therefore promote the progression of the disease.
Proteomic analysis showed the absence of Lactadherin and VE-Cadherin and enrichment of proteasome subunits in Exo-1537S, demonstrating the modulation of protein exosome cargo after ASncmtRNA knockdown. These changes in exosome cargo could negatively affect the preparation of breast cancer metastatic niches 28 . To our knowledge, this is the first report that describes the presence of two different known tumor-promoting cadherins in exosomes, suggesting a possible role of these cadherins in metastatic niche preparation. Several studies have demonstrated the role of exosomes in the promotion of metastasis, depending on their cargo 62, 63 . Our in vivo results point to the same direction, showing increase in tumor mass and metastatic sites, together with increased ascites accumulation in animals that received Lactadherin and VE-cadherin-containing Exo-WT and Exo-C in comparison to Exo-1537S recipient animals. These results suggest two possible roles of exosomal Lactadherin in the metastatic process: first, as an "adherence promotor" for the incorporation of exosome cargo into recipient cells 43 ; and second, as an "effector molecule" itself, together with VE-cadherin (among others). This could result in the modulation of different pro-metastatic processes in animal models, such as increasing vascular permeability and therefore promoting extravasation, increasing tumor cell adhesion and/or transforming the phenotype of healthy cells, granting them tumorigenic properties ( Supplementary Fig. S3 ). To date, there are no functional studies showing the participation of Lactadherin and VE-cadherin as promoters of tumorigenic capacities. Therefore, taken together, this study shows for the first time the modulation of exosome cargo derived from breast cancer cells after ASO therapy against ASncmtRNA. This therapy, along with the direct induction of cell death, abolishes the release of exosomes with pro-metastatic activity from breast cancer cells, decreasing the amount of proteins in the exosome cargo which can participate in the metastatic cascade such as Lactadherin and VE-cadherin. Further studies are under way, in order to determine if these proteins present in exosomes are responsible for the effects observed in recipient cells. Exosome isolation. Exosomes were isolated from culture supernatants of cells transfected with ASO-C (Exo-C), ASO-1537S (Exo-1537S) and untreated cells (Exo-WT), as described above. Culture media (200 ml) was subjected to an initial centrifugation at 300 × g for 10 min to remove whole cells and cell debris. Supernatant was centrifuged at 16,000 × g for 30 min at 4 °C. Subsequently, exosomes were isolated using the Exospin TM system (Cell Guidance Systems), according to manufacturer's guidelines.
Transmission electron microscopy (TEM). Exosomes were suspended in ice-cold PBS containing 2%
p-formaldehyde and mounted on copper grids, fixed in ice-cold PBS/1% glutaraldehyde for 5 minutes and washed in sterile distilled water. Grids were then contrasted with 4% uranyl acetate solution at pH 7 for 5 min and embedded in methyl cellulose-UA for 10 min on ice. Images were acquired on a Philips Tecnai 12 BioTwin transmission electron microscope (Pontificia Universidad Católica de Chile), operating at 80 kV.
Nanoparticle tracking analysis (NTA). The NanoSight NS300 (NanoSight NTA 2.3 Nanoparticle Tracking and Analysis Release Version Build 0033) (Malvern Instruments) was used to measure concentration and size of particles. Samples were diluted 1:200 in PBS and the camera was set to capture 3 videos per sample with 30 seconds of duration per video. The videos were then analyzed to determine the size distribution with an approximation to the quantity of particles.
RT-PCR amplification.
Total RNA from the lysate of MDA-MB-231 cells or MDA-MB-231 cells treated with wild type (Exo-WT), ASO-control (Exo-C) and ASO-1537S (Exo-1537) exosomes were extracted using TriZOL (Ambion) as described elsewhere 1, 2 . RNA preparations were treated with 2 U of TURBO DNA-free (Ambion) according to manufacturer's instructions. Reverse transcription was carried out with 100 ng freshly prepared RNA, 50 ng random hexamers, 20 U RNase OUT (ThermoFisher Scientific), 0.2 mM dNTPs and 200 U M-MLV reverse transcriptase (Invitrogen) in a final volume of 20 µl. Two µl cDNA were used to amplify ASncmtRNA-2 by PCR reaction in a reaction mix containing 2.5 U GoTaq (Promega), 1.5 mM MgCl 2 , 0.4 µM each dNTP and 0.2 µM of each primer in a final volumen of 50 µl. The amplification program used was: 100 °C for 10 min, 70 °C for 10 min, 80 °C for 10 min and 26 cycles consisting of 94 °C for 1 min, 58 °C for 1 min and 72 °C for 1 min. The primer sequences for amplification of ASncmtRNA-2.were: 5′ACCGTGCAAAGGTAGCATAATCA (forw) and 5′CAAGAACAGGGTTTGTTAGG (rev).
Western blot. Cells were detached by trypsinization and lysed in 0.2 mM HEPES (pH 7.4) containing 0.1% SDS, 1 mM Na 3 VO 4 (phosphatase inhibitor) and protease inhibitor cocktail (10 µg/mL benzamidine, 2 µg/mL antipain, 1 µg/mL leupeptin and 1 mM PMSF). Purified exosomes were sonicated in 0.9% NaCl containing 1 mM PMSF. Protein concentration was quantified with the Bradford microplate system Gen5TM EPOCH (BioTek). Total protein extracts (30 µg/lane) were resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride membranes (PVDF). Membranes were blocked with 5% skim milk in PBS/0.1% Tween (PBST) and then probed with antibodies against CD9 (m-monoclonal; Santa Cruz; 1:200), TSG101 (m-monoclonal; Santa Cruz; 1:200), ALIX (m-monoclonal; Cell Signaling; 1:500), Rab27a (m-monoclonal; Santa Cruz; 1:100), Calnexin (r-polyclonal; Abcam; 1:1000), HSP60 (r-polyclonal; Abcam; 1:20000), VE-Cadherin (m-monoclonal; Abcam; 1:1000), Lactadherin (m-monoclonal; Santa Cruz; 1:1000) and HSP90 (m-monoclonal; Abcam; 1:1000). Bound antibodies were then detected with peroxidase-labeled anti-mouse (Calbiochem 1:5000) or anti-rabbit (Calbiochem 1:3000) IgG. Blots were revealed with the EZ-ECL system (Biological Industries) on a C-DiGit Blot Scanner (LI-COR Biosciences) 34,36 . www.nature.com/scientificreports www.nature.com/scientificreports/ Internalization assay. Exosomes (corresponding to 20 µg of protein) were suspended in 100 µl PBS and mixed with 100 µl PKH67 fluorescent dye (Sigma-Aldrich). The mix was diluted in 5 ml PBS and the exosomes were pelleted by ultracentrifugation on a 25% sucrose cushion at 100.000 × g for 70 min at 4 °C. The exosome pellet was washed in PBS. Finally, the pellet containing PKH67-labeled exosomes was suspended in 100 µl PBS and exosomes were quantified by NTA. Exosome internalization was determined by confocal microscopy and flow cytometry. For confocal microscopy, 1 × 10 3 MDA-MB-231 cells were seeded per well in an 8-well lab-tek chamber slide (Nalge Nunc). The next day, 100 labeled exosomes per cell were added and incubated for 3 h at 37 °C. Slides were then stained with 2 µM CellTracker ™ Red CMTPX (Life Technologies), stained with 4′,6′-diaminido-2-phenylindole (DAPI; Bio Rad). Images were taken with a 100x objective of numerical aperture 1.4 on a FV1200 Laser Scanning Microscope (Olympus). For flow cytometry, 1.5 × 10 6 cells were seeded per well in 6-well plates (Nunc) and, on the next day, 100 labeled exosomes were added per cell. After 3 h, cells were detached by trypsinization and subjected to flow cytometry on a FACS Canto II cell sorter (BD Biosciences). Data was analyzed with the FlowJo Software v-7.6.1 (Tree star Inc, Stanford).
Proliferation assay. Cell proliferation was determined using the MTT Cell Proliferation Assay (ATCC), according to manufacturer's directions.
Matrigel invasion assay. MDA-MB-231 cells were serum-starved for 24 h and then seeded over
Matrigel-covered inserts (Matrigel Invasion Chamber 8.0 µm; BD Biosciences) at 1.5 × 10 5 cells/insert. Ten µg (corresponding to protein content) of exosomes (Exo-WT, Exo-C and Exo-1537S) were added and incubation proceeded for 48 h. Inserts were then fixed in 4% PFA, stained with DAPI, washed and observed under an Olympus BX53 fluorescence microscope. At least 10 fields were evaluated per insert 36 .
Spreading assay. MDA-MB-231 cells in suspension (1 × 10 5 ) were incubated in 15 ml centrifuge tubes (Nunc) for 6 h in the presence of 10 µg total exosomes (Exo-WT, Exo-C and Exo-1537S). Afterwards, cells were allowed to attach and spread for 60 min onto coverslips coated with 2 mg/ml fibronectin. Coverslips were fixed and stained with phalloidin-Rhodamine and DAPI. At least 10 images per condition were analyzed under an Olympus BX53 fluorescent microscope. Cell spreading was evaluated on the basis of phalloidin staining, using the ImageJ software. Upon threshold adjustment, the number of pixels per image was measured and normalized to the total cell number. Cell spreading at 60 min was used as an internal standard, in order to perform the pixel-to-mm 2 conversion, based on the scale of the image (in µm), the final quantification represents the increase in number per area.
Colony formation assay. Anchorage-independent cell growth was determined by colony formation in soft agar as previously described 36 . Briefly, MDA-MB-231 cells were treated with 10 µg of exosomes or left untreated for 24 h. Then, cells were seeded at 2 × 10 3 live (Tb-negative) cells/well in 12-well plates in soft agar. Formation of colonies >100 µm in diameter was scored 3 weeks after seeding under a phase-contrast microscope at 10× 36 . Animal studies. Animal studies were conducted in accordance with appropriate guidelines of Ethical Committee of Fundación Ciencia & Vida. Immune-compromised NOD/SCID mice were obtained from Jackson Laboratories (Bar Harbor, ME) and maintained in the animal facility of the Fundación Ciencia & Vida under specific pathogen-free conditions (Tecniplast SpA, Buguggiate, Italy), in a temperature-controlled environment with 12/12 h light/dark schedule and with sterile food and water ad libitum. Peritoneal carcinomatosis assay. Four groups of 7 NOD/SCID mice were inoculated intraperitoneally (ip) with 2.5 × 10 6 MDA-MB-231 cells in 250 µl saline, either alone (saline group) or together with Exo-WT, Exo-C or Exo-1537S exosomes (10 µg per mouse). An additional group of 6 NOD/SCID mice was left inoculated. Animals were euthanized on day 21 post-cell injection. Mesenterial tissue and retroperitoneal tumor mass were excised and fixed in 4% p-formaldehide. Malignant ascites was collected and total cell number was determined by Tb exclusion assay. The final evaluation in vivo was performed in a double-blinded fashion.
Proteomic analysis of exosomes. Exosomal preparations (Exo-WT, Exo-C and Exo-1537S), equivalent to 35 µg total protein, were diluted in RIPA buffer (Thermo Scientific) and sonicated in a water bath for 10 min at RT. Samples were resolved on a 10% Bis-Tris Gel (Invitrogen) and visualized using Simply Blue Safe stain (Invitrogen). Subsequently, each lane was divided into 3 fractions and each fraction was cut into approximately 1-mm gel slices. Next, gel slices were destained with 50 mM NH 4 HCO 3 and 50 mM acetonitrile (ACN). Samples were then reduced in 10 mM DTT diluted in 100 mM NH 4 HCO 3 and alkylated with 50 mM iodoacetic acid diluted in 100 mM NH 4 HCO 3 . Afterwards, samples were digested with Trypsin Gold (Promega) for 16 h at 37 °C. Peptides were extracted from the gel with 0.1% formic acid and dried. Next, 0.1% trifluoroacetic acid was used to reconstitute samples, which were eluted in different proportions of TFA/ACN using a C18 solid phase extraction 96 well-plate (Shimadzu). Vacuum centrifuge-dried samples were resuspended in 0.1% formic acid and stored in screw thread glass autosampler vials (Thermo Fisher). Peptides were analysed by liquid chromatography (LC)/mass spectrometry (MS) (LC-MS/MS) on a TripleTOF5600 mass spectrometer (ABSciex) equipped with an Eksigent 1D + NanoLC system with an cHiPLC system. Once injected into de column, the resulting peptide mixture was separated using a linear gradient of Buffer A containing 0.1% formic acid/water and Buffer B which contained acetonitrile/0.1% formic acid. MS/MS spectra were collected using the Information Dependent Acquisition (IDA) with a survey scan (m/z 350-1500) along with 25 data-dependent product ion scans of the 25 most intense precursor ions. All mass spectra were analyzed using Protein PilotTM software with the Paragon method as a search engine against the Uniprot-database (setting human as default species). False discovery rate www.nature.com/scientificreports www.nature.com/scientificreports/ (FDR) was estimated using a reversed sequence database. Data was subjected to ontology and pathway analysis using the protein analysis through evolutionary relationships tool (PANTHER) and gene ontology algorithms and classified based on pathway, biological process and molecular function categories.
Statistical analysis.
The Kruskal-Wallis test was used, followed by Dunn's multiple comparison post-test.
For invasion and in vivo experiments, results were compared using unpaired t-tests and corroborated with Tukey by multiple comparison post-test. Quantitative Western blot analysis was analyzed using unpaired t-test and one-way ANOVA.
